Approval · Notice of Compliance 28832 · 2022
PLUVICTO: Notice of Compliance 28832
Issued August 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28832
- Date
- August 25, 2022
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLUVICTO | 02530198 | Marketed |
Medicinal ingredients
- LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN 1,000 MBQ per ML